MiMedx Group, Inc. (OTC BB: MDXG)is focused on developing biomaterial-based products for application in the musculoskeletal specialties. The company intends to leverage their experienced management team to commercializes medical technologies by facilitating their progression through the proper regulatory approval processes, arranging for reliable and cost-effective manufacturing, and delivering these products to markets throughout the world. For further information, visit the Company’s web site at www.mimedx.com.
- 17 years ago
QualityStocks
MiMedx Group, Inc. (OTC BB: MDXG)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
Clene (NASDAQ: CLNN), a clinical-stage biopharmaceutical company developing treatments for neurodegenerative diseases such as ALS and…
-
QualityStocksNewsBreaks – FAVO Capital (OTC: FAVO) Acquires $190 Million Mixed-Use Property 1818 Park in All-Stock Deal
FAVO Capital (OTC: FAVO), a diversified finance company providing alternative revenue-based funding to SMBs, completed its…
-
QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (OTC: GTVH) Acquires Go Fast Sports Brand in Move Into Functional Beverage Market
Golden Triangle Ventures (OTC: GTVH) (“GTV”) reached an agreement with Labor Smart, Inc. (OTC: LTNC) to…